{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T12:28:56Z","timestamp":1707654536111},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/naika.102.63","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T23:03:32Z","timestamp":1389308612000},"page":"63-69","source":"Crossref","is-referenced-by-count":0,"title":["3. Functional Dyspepsia","3\uff0e\u6a5f\u80fd\u6027\u30c7\u30a3\u30b9\u30da\u30d7\u30b7\u30a2"],"prefix":"10.2169","volume":"102","author":[{"given":"Hidekazu","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Keio University School of Medicine"},{"name":"Department of Gastroenterology, National Tokyo Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Stanghellini V: Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic\/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 231: 20-28, 1999.","DOI":"10.1080\/003655299750025237"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tack J: Functional Dyspepsia: Impaired Fundic Accommodation. Curr Treat Options Gastroenterol 3: 287-294, 2000.","DOI":"10.1007\/s11938-000-0042-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tack J, et al: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121: 526-535, 2001.","DOI":"10.1053\/gast.2001.27180"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Talley NJ, et al: Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther 23: 923-936, 2006.","DOI":"10.1111\/j.1365-2036.2006.02845.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Suzuki H: Post-infectious Functional Dyspepsia-A Novel Disease Entity among Functional Gastrointestinal Disorders-Relation to <i>Helicobacter pylori<\/i> Infection? (Neurogastroenterol Motil 2009; 21: 832-e56). J Neurogastroenterol Motil 16: 97-98, 2010.","DOI":"10.5056\/jnm.2010.16.1.97"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mearin F, et al: Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129: 98-104, 2005.","DOI":"10.1053\/j.gastro.2005.04.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Moayyedi P: The health economics of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21: 347-361, 2007.","DOI":"10.1016\/j.bpg.2006.11.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gwee KA, et al: The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 21: 417-424, 2009.","DOI":"10.1097\/MEG.0b013e328317b89e"},{"key":"9","unstructured":"9) Dhali GK, et al: Role of anti-<i>Helicobacter pylori<\/i> treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians. J Gastroenterol Hepatol 14: 523-528, 1999."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jin X, Li YM: Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia. Helicobacter 12: 541-546, 2007.","DOI":"10.1111\/j.1523-5378.2007.00520.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Suzuki H, et al: Improvement of gastrointestinal quality of life scores in cases of <i>Helicobacter pylori<\/i>-positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol 20: 1652-1660, 2005.","DOI":"10.1111\/j.1440-1746.2005.04039.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Saito Y, et al: The role of microRNAs in gastrointestinal cancers. J Gastroenterol 44 (Suppl 19): 18-22, 2009.","DOI":"10.1007\/s00535-008-2285-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Suzuki H, et al: Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol 26 (Suppl 3): 42-45, 2011.","DOI":"10.1111\/j.1440-1746.2011.06629.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Suzuki H, et al: What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil 17: 124-130, 2011.","DOI":"10.5056\/jnm.2011.17.2.124"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sugano K: Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease? J Neurogastroenterol Motil 17: 366-371, 2011.","DOI":"10.5056\/jnm.2011.17.4.366"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nishizawa T, et al: Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther 24 (suppl 4): 104-110, 2006.","DOI":"10.1111\/j.1365-2036.2006.00032.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kim YS, et al: Plasma levels of acylated ghrelin in patients with functional dyspepsia. World J Gastroenterol 18: 2231-2237, 2012.","DOI":"10.3748\/wjg.v18.i18.2231"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Suzuki H, et al: <i>Helicobacter pylori<\/i> infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 53: 187-194, 2004.","DOI":"10.1136\/gut.2003.021568"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Akamizu T, et al: Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 158: 491-498, 2008.","DOI":"10.1530\/EJE-07-0768"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Arai M, et al: Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 59: 62-66, 2012.","DOI":"10.5754\/hge11246"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tack J, et al: Functional gastroduodenal disorders. Gastroenterology 130: 1466-1479, 2006.","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Suzuki H, et al: Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol 41: 513-523, 2006.","DOI":"10.1007\/s00535-006-1847-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Matsuzaki J, et al: Classification of functional dyspepsia based on concomitant bowel symptoms. Neurogastroenterol. Motil 24: 325-e164, 2012.","DOI":"10.1111\/j.1365-2982.2011.01859.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Matsuzaki J, et al: High frequency of overlap between functional dyspepsia and overactive bladder. Neurogastroenterol. Motil 24: 821-827, 2012.","DOI":"10.1111\/j.1365-2982.2012.01939.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Suzuki H, et al: <i>Helicobacter pylori<\/i> eradication therapy. Future Microbiol 5: 639-648, 2010.","DOI":"10.2217\/fmb.10.25"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nishizawa T, et al: Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils. Digestion 79: 99-108, 2009.","DOI":"10.1159\/000209219"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Asaka M, et al: Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15: 1-20, 2010.","DOI":"10.1111\/j.1523-5378.2009.00738.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Miwa H, et al: Asian consensus report on functional dyspepsia. J Gastroenterol Hepatol 27: 626-641, 2012.","DOI":"10.1111\/j.1440-1746.2011.07037.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Geeraerts B, Tack J: Functional dyspepsia: past, present, and future. J Gastroenterol 43: 251-255, 2008.","DOI":"10.1007\/s00535-008-2167-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Moayyedi P, et al: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev CD001960, 2006.","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wang WH, et al: Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 5: 178-185; quiz 140. 2007.","DOI":"10.1016\/j.cgh.2006.09.012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Braak B, et al: Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study. Aliment Pharmacol Ther 34: 638-648, 2011.","DOI":"10.1111\/j.1365-2036.2011.04775.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Suzuki H, et al: Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil 21: 688-696, 2009.","DOI":"10.1111\/j.1365-2982.2009.01290.x"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/1\/102_63\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T22:14:33Z","timestamp":1647987273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/1\/102_63\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.102.63","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}